文献速递颈动脉与弓上血管

Willis覆膜支架治疗颈内动脉复杂血管病变的安全性与有效性

Efficacy and Safety of Willis Covered Stent for Treatment of Complex Vascular Diseases of the Internal Carotid Artery.
PubMed 文献 · Ann Vasc Surg · 2019-08-02

本研究回顾性分析13例颈内动脉复杂病变患者接受Willis覆膜支架治疗的结果,技术成功率92.3%,随访6-10个月无复发、出血或支架内狭窄,无操作相关并发症或死亡。结论认为Willis覆膜支架治疗颈内动脉复杂病变安全有效,但需更长随访及大样本多中心研究证实。

要点

  • Willis覆膜支架治疗颈内动脉复杂病变技术成功率92.3%。
  • 随访6-10个月无动脉瘤复发、出血,载瘤动脉通畅无狭窄。
  • 无操作相关并发症或死亡,但需大样本长期随访验证。

核心结论

  • Willis覆膜支架植入治疗颈内动脉复杂血管病变安全有效。
  • 仍需更长随访、大样本对照研究及多中心研究进一步确认。

研究设计与样本

  • 回顾性分析2016年10月至2018年1月在本机构接受Willis覆膜支架系统治疗的13例颈内动脉复杂病变患者。
  • 治疗后约6-10个月进行随访观察和数字减影血管造影(DSA)检查。

主要发现

  • 12例颈内动脉复杂血管病变成功治疗,技术成功率为92.3%。
  • 13个病变包括血泡样动脉瘤7例、外伤性假性动脉瘤1例、外伤性颈动脉破裂1例、动脉瘤伴动静脉瘘4例。
  • 13例患者共置入15枚Willis覆膜支架,释放部位为颈内动脉C7段2枚、C6段1枚、C5和/或C4段9枚、C2段3枚。
  • 支架置入后即刻DSA显示11例病变完全闭塞,2例观察到内漏。
  • 11例术后DSA复查显示病变完全闭塞;2例在颈内动脉破裂处二次置入支架的患者中,1例外伤性颈内动脉破裂基本完全闭塞,1例颈动脉海绵窦瘘因颈内动脉迂曲难以置入第二枚支架系统而内漏持续存在。

临床怎么用

  • Willis覆膜支架可作为颈内动脉复杂血管病变(如血泡样动脉瘤、外伤性假性动脉瘤/破裂、动脉瘤伴动静脉瘘)的一种治疗选择。
  • 术后约6-10个月行DSA随访评估病变闭塞及载瘤动脉通畅情况。
  • 对于颈内动脉迂曲患者,需评估二次置入支架系统的可行性及内漏风险。

局限性

  • 回顾性研究,样本量小(13例)。
  • 随访时间较短(约6-10个月)。
  • 单中心研究,需大样本对照及多中心研究进一步确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Willis covered stents are used in clinical practice for some complex cerebrovascular diseases. However, the performance of the Willis covered stent requires further investigation. In this study, we investigate the safety and efficacy of Willis covered stents for the treatment of complex vascular diseases of the internal carotid artery (ICA). METHODS: Thirteen patients with complex ICA diseases treated with the Willis covered stent system at our institution from October 2016 to January 2018 were analyzed retrospectively. Follow-up observation and digital subtraction angiography (DSA) examination were conducted at about 6-10 months after the treatment. RESULTS: The complex vascular diseases of the ICA were successfully treated in 12 patients. The technical success rate was 92.3%. Pathologically, 13 lesions included blood blister-like aneurysm (n = 7), traumatic pseudoaneurysm (n = 1), traumatic carotid artery rupture (n = 1), and aneurysm with arteriovenous fistula (n = 4). Thirteen patients with complex vascular diseases of the ICA were treated with 15 Willis covered stents. The release sites of Willis covered stents were the C7 (n = 2), C6 (n = 1), C5 and/or C4 (n = 9), and the C2 (n = 3) segment of the ICA. DSA performed immediately after stent deployment revealed that complete occlusion of the lesion was achieved in 11 patients and endoleak was observed in 2 patients. Of the 11 patients, postoperative DSA examination indicated that the lesions were occluded completely. Among 2 patients, who had a second stent implantation at the break of the ICA, the traumatic ICA rupture was essentially completely obstructed in 1 patient. The endoleak remained in 1 patient with carotid cavernous sinus fistula because the placement of the second stent system was difficult with his ICA tortuosity. No recurrence of aneurysms, hemorrhagia, and other lesions was observed, and the patients' parent arteries were patent without stenosis. No procedure-related complications or deaths occurred during follow-up. CONCLUSIONS: For the treatment of complex vascular diseases in the ICA, Willis covered stent implantation is safe and effective. However, longer follow-up, large-sample controlled studies, and multicenter studies are needed for further confirmation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Liu Y, Yang HF, Xiong ZY, et al. Efficacy and Safety of Willis Covered Stent for Treatment of Complex Vascular Diseases of the Internal Carotid Artery. Ann Vasc Surg. 2019. PMID: 31381999. doi:10.1016/j.avsg.2019.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。